$58.42
0.190.33%
At Close: -
$58.42
00.00%
After Hours: 4:05 PM EDT
15 minutes delayed
Comments
Loading...
Catalent
CTLTNYSE
Catalent (NYSE:CTLT) Stock, Insider Trading Activity
Catalent: Insider buying and selling updated today.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Catalent Inc Insiders Doing?
At Catalent Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 2.99K shares worth $169.82K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On June 5, 2024, Ricky Hopson, the company's PRES. BIOPRODUCT DELIVERY, COS sold 1.4K shares for $54.26 each.
- On July 10, 2024, Matti Masanovich, the company's SVP, CHIEF FINANCIAL OFFICER sold 2.99K shares for $56.74 each.
Ownership Statistics for Catalent Inc
Institutional Shares Held
123.239M
Institutional Percentage Held
68.1%
| Jul 10, 2024 | Matti Masanovich | SVP, CHIEF FINANCIAL OFFICER | -2.99K | $56.74 | -$169.82K | SELL | -8.12% | 33.87K | Jul 08 | View |
| Jun 05, 2024 | Ricky Hopson | PRES. BIOPRODUCT DELIVERY, COS | -1.40K | $54.26 | -$76.02K | SELL | -6.36% | 20.62K | Jun 04 | View |
| Mar 19, 2024 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | -387.00 | $56.20 | -$21.75K | SELL | -1.29% | 29.51K | Mar 15 | View |
| Sep 05, 2023 | Michelle Ryan | DIRECTOR | 1.00K | $49.98 | $49.98K | BUY | 102.15% | 1.98K | Aug 31 | View |
| Sep 01, 2023 | JOHN GREISCH | EXECUTIVE CHAIR | 21.00K | $50.24 | $1.06M | BUY | 71.93% | 50.20K | Aug 30 | View |
| Aug 25, 2023 | Alessandro Maselli | PRESIDENT & CEO | 1.90K | $44.54 | -$92.24K | GRANT | 2.21% | 88.00K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | 812.00 | $44.57 | -$11.99K | GRANT | 2.79% | 29.93K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | 724.00 | $44.50 | -$17.36K | GRANT | 3.05% | 24.45K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Aristippos Gennadios | GROUP PRES. PHARMA & CONSUMER | 1.19K | $44.49 | -$17.62K | GRANT | 1.25% | 96.55K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Steven Fasman | EVP & CHIEF ADMIN OFFICER | 1.41K | $44.65 | -$36.48K | GRANT | 1.95% | 73.79K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Lorenzo Carletti | SVP GLOBAL OPS PH & CONS HLTH | 241.00 | $44.71 | -$9.66K | GRANT | 2.83% | 8.75K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Jonathan Arnold | SVP, CCO & DIV. HEAD BIOP DEL. | 1.50K | $44.87 | -$3.90K | GRANT | 2.69% | 57.40K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Ricky Hopson | PRES. CLINICAL DEV SUPPLY DIV | 513.00 | $44.56 | -$12.30K | GRANT | 2.38% | 22.04K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Thomas Hawkeswood | PRES. PHARMA PROD DELIVERY DIV | 121.00 | $44.72 | -$6.57K | GRANT | 1.63% | 7.53K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Charles Lickfold | SVP, CIO | 447.00 | $44.72 | -$8.50K | GRANT | 4.10% | 11.34K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Patricia Hunt | PRES. CONSUMER HEALTH DIV | 183.00 | $44.77 | -$4.75K | GRANT | 1.65% | 11.29K | Aug 23 - Aug 24 | View |
| Aug 25, 2023 | Ricardo Pravda | CHIEF TRANSFORMATION OFFICER | 702.00 | $44.47 | -$16.85K | GRANT | 2.38% | 30.22K | Aug 23 - Aug 24 | View |
| Aug 03, 2023 | Ricardo Pravda | CHIEF TRANSFORMATION OFFICER | 9.51K | $47.56 | -$12.79K | GRANT | 47.55% | 29.52K | Aug 01 | View |
| Aug 03, 2023 | Alessandro Maselli | PRESIDENT & CEO | -1.49K | $47.13 | -$69.99K | SELL | -1.70% | 86.10K | Aug 01 | View |
| Aug 03, 2023 | Charles Lickfold | SVP, CIO | 5.19K | $47.90 | -$6.47K | GRANT | 90.92% | 10.89K | Aug 01 | View |
| Aug 03, 2023 | Patricia Hunt | PRES. CONSUMER HEALTH DIV | 1.79K | $47.95 | -$7.72K | GRANT | 19.23% | 11.11K | Aug 01 | View |
| Aug 03, 2023 | Ricky Hopson | PRES. CLINICAL DEV SUPPLY DIV | 4.59K | $47.86 | -$9.33K | GRANT | 27.93% | 21.05K | Aug 01 | View |
| Aug 03, 2023 | Thomas Hawkeswood | PRES. PHARMA PROD DELIVERY DIV | 2.05K | $47.97 | -$12.38K | GRANT | 38.18% | 7.41K | Aug 01 | View |
| Aug 03, 2023 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | 5.13K | $47.90 | -$9.10K | GRANT | 21.39% | 29.12K | Aug 01 | View |
| Aug 03, 2023 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | 5.93K | $47.72 | -$13.17K | GRANT | 33.35% | 23.73K | Aug 01 | View |
| Aug 03, 2023 | Aristippos Gennadios | GROUP PRES. PHARMA & CONSUMER | 8.59K | $47.59 | -$13.37K | GRANT | 9.90% | 95.36K | Aug 01 | View |
| Aug 03, 2023 | Lorenzo Carletti | SVP GLOBAL OPS PH & CONS HLTH | 3.52K | $47.77 | -$18.30K | GRANT | 70.61% | 8.51K | Aug 01 | View |
| Aug 03, 2023 | Jonathan Arnold | SVP, CCO & DIV. HEAD BIOP DEL. | -62.00 | $47.80 | -$2.96K | SELL | -0.11% | 55.90K | Aug 01 | View |
| Aug 03, 2023 | Steven Fasman | EVP & CHIEF ADMIN OFFICER | 10.25K | $47.05 | -$77.03K | GRANT | 16.57% | 72.10K | Aug 01 | View |
| May 03, 2023 | Manja Boerman | PRES. BIOMODALITIES DIVISION | -1.45K | $49.86 | -$72.10K | SELL | -9.12% | 14.41K | May 01 | View |
| May 03, 2023 | Mario Gargiulo | SVP, OPS, BIOLOGICS EUROPE | -678.00 | $49.86 | -$33.81K | SELL | -10.67% | 5.68K | May 01 | View |
| Jan 25, 2023 | Ricky Hopson | PRES. CLINICAL DEV SUPPLY DIV | -643.00 | $49.36 | -$31.74K | SELL | -3.76% | 16.45K | Jan 23 | View |
| Dec 07, 2022 | Manja Boerman | PRES. BIOMODALITIES DIVISION | -780.00 | $51.70 | -$40.33K | SELL | -4.69% | 15.86K | Dec 05 | View |
| Nov 02, 2022 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | -2.45K | $65.83 | -$161.35K | SELL | -12.11% | 17.79K | Oct 31 | View |
| Oct 12, 2022 | Thomas Hawkeswood | PRES. PHARMA PROD DELIVERY DIV | -930.00 | $77.46 | -$72.04K | SELL | -14.78% | 5.36K | Oct 10 | View |
| Sep 02, 2022 | Ricky Hopson | PRES. CLINICAL DEV SUPPLY DIV | -2.22K | $89.59 | -$198.53K | SELL | -11.48% | 17.09K | Aug 31 | View |
| Aug 30, 2022 | Michael Riley | PRES. BIO PRODUCT DELIVERY DIV | -2.49K | $104.07 | -$259.24K | SELL | -27.42% | 6.59K | Aug 26 | View |
| Aug 30, 2022 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | -1.64K | $104.07 | -$170.57K | SELL | -6.40% | 23.99K | Aug 26 | View |
| Aug 26, 2022 | Kay Schmidt | SVP, ENTERPRISE FUNCTIONS | 2.82K | $103.04 | -$136.12K | GRANT | 19.34% | 17.39K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Michael Riley | PRES. BIO PRODUCT DELIVERY DIV | 2.49K | $103.04 | -$152.71K | GRANT | 37.79% | 9.08K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Ricardo Pravda | SVP & CHIEF HR OFFICER | 3.37K | $103.04 | -$180.01K | GRANT | 20.25% | 20.01K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Alessandro Maselli | PRESIDENT & CEO | 5.89K | $103.04 | -$478.72K | GRANT | 16.67% | 41.19K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Patricia Hunt | PRES. CONSUMER HEALTH DIV | 610.00 | $103.04 | -$34.93K | GRANT | 7.01% | 9.31K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Ricky Hopson | PRES. CLINICAL DEV SUPPLY DIV | 2.22K | $103.04 | -$156.31K | GRANT | 12.96% | 19.31K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Thomas Hawkeswood | PRES. PHARMA PROD DELIVERY DIV | 582.00 | $103.04 | -$69.14K | GRANT | 10.19% | 6.29K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | 3.28K | $103.04 | -$189.59K | GRANT | 14.66% | 25.63K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | 3.22K | $103.04 | -$172.08K | GRANT | 18.92% | 20.24K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Aristippos Gennadios | GROUP PRES. PHARMA & CONSUMER | 5.13K | $103.04 | -$169.50K | GRANT | 6.28% | 86.77K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Mario Gargiulo | SVP GLOBAL OPS BIOLOGICS | 1.85K | $103.04 | -$163.42K | GRANT | 40.95% | 6.35K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Steven Fasman | EVP & CHIEF ADMIN OFFICER | 5.34K | $103.04 | -$495.73K | GRANT | 9.46% | 61.85K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | John Chiminski | EXECUTIVE CHAIR | 60.34K | $103.04 | -$4.01M | GRANT | 35.59% | 229.89K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Thomas Castellano | SVP, CHIEF FINANCIAL OFFICER | 2.73K | $103.04 | -$145.70K | GRANT | 15.68% | 20.10K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Lorenzo Carletti | SVP GLOBAL OPS PH & CONS HLTH | 1.20K | $103.04 | -$106.44K | GRANT | 31.67% | 4.99K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Manja Boerman | PRES. BIOMODALITIES DIVISION | 3.38K | $103.04 | -$339.62K | GRANT | 25.49% | 16.64K | Aug 24 - Aug 25 | View |
| Aug 26, 2022 | Jonathan Arnold | SVP & CHIEF COMMERCIAL OFCR | 6.24K | $103.04 | -$39.57K | GRANT | 12.54% | 55.96K | Aug 24 - Aug 25 | View |
| Jul 28, 2022 | Kay Schmidt | SVP, ENTERPRISE FUNCTIONS | 792.00 | $106.90 | -$34.53K | GRANT | 5.75% | 14.57K | Jul 26 | View |
| Jul 28, 2022 | Ricardo Pravda | SVP & CHIEF HR OFFICER | 874.00 | $106.90 | -$45.65K | GRANT | 5.54% | 16.64K | Jul 26 | View |
| Jul 28, 2022 | Alessandro Maselli | PRESIDENT & CEO | 9.40K | $106.90 | -$87.23K | GRANT | 36.31% | 35.30K | Jul 26 | View |
| Jul 28, 2022 | Ricky Hopson | PRES, CLINICAL DEV & SUPPLY | -252.00 | $107.40 | -$96.99K | SELL | -1.45% | 17.09K | Jul 26 - Jul 27 | View |
| Jul 28, 2022 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | 271.00 | $107.26 | -$90.53K | GRANT | 1.23% | 22.35K | Jul 26 - Jul 27 | View |
| Jul 28, 2022 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | 504.00 | $107.27 | -$85.50K | GRANT | 3.05% | 17.02K | Jul 26 - Jul 27 | View |
| Jul 28, 2022 | Aristippos Gennadios | GROUP PRES. PHARMA & CONSUMER | 1.46K | $106.90 | -$43.08K | GRANT | 1.82% | 81.64K | Jul 26 | View |
| Jul 28, 2022 | Mario Gargiulo | SVP GLOBAL OPS BIOLOGICS | -132.00 | $106.90 | -$103.59K | SELL | -2.84% | 4.51K | Jul 26 | View |
| Jul 28, 2022 | Steven Fasman | EVP & CHIEF ADMIN OFFICER | 242.00 | $106.90 | -$272.17K | GRANT | 0.43% | 56.51K | Jul 26 | View |
| Jul 28, 2022 | John Chiminski | EXECUTIVE CHAIR | 27.47K | $106.90 | -$1.04M | GRANT | 19.34% | 169.55K | Jul 26 | View |
| Jul 28, 2022 | Thomas Castellano | SVP, CHIEF FINANCIAL OFFICER | 1.98K | $106.90 | -$37.09K | GRANT | 12.83% | 17.37K | Jul 26 | View |
| Jul 28, 2022 | Lorenzo Carletti | SVP GLOBAL OPS PH & CONS HLTH | 206.00 | $106.90 | -$67.45K | GRANT | 5.75% | 3.79K | Jul 26 | View |
| Jul 28, 2022 | Jonathan Arnold | SVP & CHIEF COMMERCIAL OFCR | 929.00 | $106.90 | -$10.05K | GRANT | 1.90% | 49.72K | Jul 26 | View |
| Jun 13, 2022 | Mario Gargiulo | SVP GLOBAL OPS LARGE MOLECULE | -118.00 | $106.59 | -$12.58K | SELL | -2.48% | 4.64K | Jun 10 | View |
| Jun 13, 2022 | Steven Fasman | SVP & GENERAL COUNSEL | -5.00K | $107.07 | -$535.35K | SELL | -8.17% | 56.18K | Jun 10 | View |
| Feb 08, 2022 | Peter Zippelius | DIRECTOR | -487.09K | $102.65 | -$50.00M | SELL | -10.09% | 4.34M | Feb 06 | View |
| Feb 01, 2022 | Ricky Hopson | VP, CHIEF ACCOUNTING OFFICER | -2.33K | $103.39 | -$240.38K | SELL | -11.99% | 17.07K | Jan 31 | View |
| Jan 24, 2022 | Ricci Whitlow | PRESIDENT, CSS | -184.00 | $102.37 | -$18.84K | SELL | -5.92% | 2.92K | Jan 21 | View |
| Jan 11, 2022 | Karen Flynn | CHIEF COMMERCIAL OFFICER | -2.47K | $116.64 | -$288.33K | SELL | -6.93% | 33.22K | Jan 10 | View |
| Dec 01, 2021 | Peter Zippelius | DIRECTOR | 4.82M | $89.42 | -$344.21K | SELL-OPTIONS | 61595.73% | 4.83M | Nov 18 - Nov 30 | View |
| Nov 24, 2021 | GREGORY LUCIER | DIRECTOR | -5.07K | $127.35 | -$645.41K | SELL | -19.36% | 21.11K | Nov 23 | View |
| Nov 03, 2021 | Jonathan Arnold | PRES. ORAL & SPECIALTY DELIV. | -3.11K | $92.40 | -$1.16M | SELL | -6.90% | 41.97K | Nov 01 | View |
| Oct 21, 2021 | Thomas Castellano | SVP, CHIEF FINANCIAL OFFICER | -2.31K | $134.00 | -$309.14K | SELL | -13.03% | 15.40K | Oct 20 | View |
| Oct 18, 2021 | Jonathan Arnold | PRES. ORAL & SPECIALTY DELIV. | -1.66K | $129.41 | -$214.95K | SELL | -3.55% | 45.08K | Oct 14 | View |
| Oct 06, 2021 | Kay Schmidt | SVP, TECHNICAL OPERATIONS | -2.19K | $131.25 | -$287.57K | SELL | -13.72% | 13.78K | Oct 04 | View |
| Oct 06, 2021 | Steven Fasman | SVP & GENERAL COUNSEL | -17.45K | $90.28 | -$3.59M | SELL | -23.40% | 57.13K | Oct 04 | View |
| Oct 05, 2021 | Ricardo Pravda | SVP & CHIEF HR OFFICER | -1.09K | $97.99 | -$409.23K | SELL | -8.48% | 11.75K | Oct 01 | View |
| Oct 05, 2021 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | -2.06K | $131.66 | -$270.56K | SELL | -14.12% | 12.50K | Oct 01 | View |
| Oct 05, 2021 | John Chiminski | CHAIR & CEO | -76.80K | $85.14 | -$16.99M | SELL | -35.09% | 142.07K | Oct 01 | View |
| Aug 30, 2021 | Thomas Castellano | SVP, CHIEF FINANCIAL OFFICER | 2.18K | $131.13 | -$274.46K | GRANT | 14.04% | 17.70K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Kay Schmidt | SVP, TECHNICAL OPERATIONS | 1.76K | $131.13 | -$108.18K | GRANT | 12.43% | 15.97K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Ricky Hopson | VP, CHIEF ACCOUNTING OFFICER | 2.85K | $131.13 | -$192.89K | GRANT | 17.19% | 19.40K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Ricardo Pravda | SVP & CHIEF HR OFFICER | 1.34K | $131.13 | -$90.74K | GRANT | 11.64% | 12.84K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Alessandro Maselli | PRESIDENT & COO | 4.26K | $131.13 | -$490.82K | GRANT | 19.71% | 25.90K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | 1.88K | $130.78 | -$545.73K | GRANT | 11.61% | 18.06K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | 3.29K | $131.13 | -$222.66K | GRANT | 29.15% | 14.56K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Aristippos Gennadios | PRESIDENT SOFTGEL & ORAL TECH | 5.75K | $131.13 | -$296.62K | GRANT | 11.11% | 57.48K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Steven Fasman | SVP & GENERAL COUNSEL | 5.46K | $131.13 | -$801.34K | GRANT | 7.89% | 74.59K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | John Chiminski | CHAIR & CEO | 60.93K | $131.06 | -$5.83M | GRANT | 36.07% | 229.87K | Aug 26 - Aug 27 | View |
| Aug 30, 2021 | Jonathan Arnold | PRES. ORAL & SPECIALTY DELIV. | 7.38K | $131.13 | -$59.27K | GRANT | 18.74% | 46.74K | Aug 26 - Aug 27 | View |
| Aug 23, 2021 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | -5.93K | $55.94 | -$331.86K | SELL | -33.74% | 11.65K | Dec 19 - Jan 13 | View |
| Jul 28, 2021 | Thomas Castellano | SVP, CHIEF FINANCIAL OFFICER | 507.00 | $113.05 | -$62.74K | GRANT | 3.38% | 15.53K | Jul 26 | View |
| Jul 28, 2021 | Kay Schmidt | SVP, TECHNICAL OPERATIONS | 338.00 | $113.05 | -$61.84K | GRANT | 2.44% | 14.20K | Jul 26 | View |
| Jul 28, 2021 | Ricky Hopson | VP, CHIEF ACCOUNTING OFFICER | 136.00 | $113.05 | -$40.70K | GRANT | 0.83% | 16.55K | Jul 26 | View |
| Jul 28, 2021 | Ricardo Pravda | SVP & CHIEF HR OFFICER | 427.00 | $113.05 | -$51.78K | GRANT | 3.86% | 11.50K | Jul 26 | View |
| Jul 28, 2021 | Alessandro Maselli | PRESIDENT & COO | 2.02K | $113.05 | -$112.26K | GRANT | 10.28% | 21.63K | Jul 26 | View |
| Jul 28, 2021 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | -326.00 | $113.04 | -$121.97K | SELL | -1.97% | 16.18K | Jul 26 | View |
| Jul 28, 2021 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | 523.00 | $113.05 | -$50.99K | GRANT | 3.07% | 17.58K | Jul 26 | View |
| Jul 28, 2021 | Aristippos Gennadios | PRESIDENT SOFTGEL & ORAL TECH | 420.00 | $113.05 | -$52.57K | GRANT | 0.82% | 51.73K | Jul 26 | View |
| Jul 28, 2021 | Steven Fasman | SVP & GENERAL COUNSEL | 221.00 | $113.05 | -$175.11K | GRANT | 0.32% | 69.13K | Jul 26 | View |
| Jul 28, 2021 | John Chiminski | CHAIR & CEO | 5.32K | $113.05 | -$1.26M | GRANT | 3.25% | 168.94K | Jul 26 | View |
| Jul 28, 2021 | Jonathan Arnold | PRES. ORAL & SPECIALTY DELIV. | 765.00 | $113.05 | -$13.57K | GRANT | 1.98% | 39.37K | Jul 26 | View |
| Jul 16, 2021 | Steven Fasman | SVP & GENERAL COUNSEL | -4.50K | $109.86 | -$494.35K | SELL | -6.13% | 68.91K | Jul 15 | View |
| Jun 24, 2021 | Ricardo Pravda | SVP & CHIEF HR OFFICER | -2.80K | $110.58 | -$309.62K | SELL | -20.19% | 11.07K | Jun 23 | View |
| Mar 23, 2021 | Kay Schmidt | SVP, TECHNICAL OPERATIONS | -1.40K | $105.77 | -$148.08K | SELL | -9.17% | 13.87K | Mar 22 | View |
| Mar 22, 2021 | Steven Fasman | SVP & GENERAL COUNSEL | 0.00 | $71.65 | -$1.42M | SELL-OPTIONS | 0.00% | 73.31K | Mar 18 | View |
| Mar 22, 2021 | John Chiminski | CHAIR & CEO | 0.00 | $73.39 | -$14.62M | SELL-OPTIONS | 0.00% | 163.62K | Mar 18 - Mar 19 | View |
| Feb 18, 2021 | Wetteny Joseph | SVP & CHIEF FINANCIAL OFFICER | 0.00 | $88.55 | -$359.89K | SELL-OPTIONS | 0.00% | 49.82K | Feb 16 | View |
| Feb 10, 2021 | Wetteny Joseph | SVP & CHIEF FINANCIAL OFFICER | -4.60K | $113.73 | -$523.61K | SELL | -8.46% | 49.82K | Feb 08 | View |
| Jan 25, 2021 | Ricci Whitlow | PRESIDENT, CSS | -692.00 | $118.85 | -$82.24K | SELL | -21.18% | 2.58K | Jan 21 | View |
| Jan 11, 2021 | Karen Flynn | PRES. BIOLOGICS & CCO | -2.48K | $112.30 | -$278.28K | SELL | -6.69% | 34.54K | Jan 11 | View |
| Jan 07, 2021 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | -61.00 | $104.78 | -$6.39K | SELL | -0.37% | 16.51K | Jan 06 | View |
| Jan 05, 2021 | Ricci Whitlow | PRESIDENT, CSS | -83.00 | $104.42 | -$8.67K | SELL | -2.48% | 3.27K | Jan 04 | View |
| Jan 05, 2021 | Kay Schmidt | SVP, TECHNICAL OPERATIONS | -73.00 | $104.42 | -$7.62K | SELL | -0.48% | 15.27K | Jan 04 | View |
| Jan 05, 2021 | Ricardo Pravda | SVP & CHIEF HR OFFICER | -78.00 | $104.42 | -$8.14K | SELL | -0.56% | 13.87K | Jan 04 | View |
| Jan 05, 2021 | Alessandro Maselli | PRESIDENT & COO | -148.00 | $104.42 | -$15.45K | SELL | -0.75% | 19.62K | Jan 04 | View |
| Jan 05, 2021 | Wetteny Joseph | SVP & CHIEF FINANCIAL OFFICER | -172.00 | $104.42 | -$17.96K | SELL | -0.32% | 54.43K | Jan 04 | View |
| Jan 05, 2021 | Scott Gunther | SVP, QUALITY & REG. AFFAIRS | -120.00 | $104.42 | -$12.53K | SELL | -0.72% | 16.57K | Jan 04 | View |
| Jan 05, 2021 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | -126.00 | $104.42 | -$13.16K | SELL | -0.73% | 17.08K | Jan 04 | View |
| Jan 05, 2021 | Aristippos Gennadios | PRESIDENT SOFTGEL & ORAL TECH | -110.00 | $104.42 | -$11.49K | SELL | -0.21% | 51.31K | Jan 04 | View |
| Jan 05, 2021 | Karen Flynn | PRES. BIOLOGICS & CCO | -99.00 | $104.42 | -$10.34K | SELL | -0.27% | 37.02K | Jan 04 | View |
| Jan 05, 2021 | Steven Fasman | SVP & GENERAL COUNSEL | -189.00 | $104.42 | -$19.74K | SELL | -0.26% | 73.31K | Jan 04 | View |
| Jan 05, 2021 | Jonathan Arnold | PRES. ORAL & SPECIALTY DELIV. | -16.00 | $104.42 | -$1.67K | SELL | -0.04% | 38.60K | Jan 04 | View |
| Dec 23, 2020 | Aristippos Gennadios | — | 0.00 | $67.76 | -$958.52K | OPTION EXERCISE | 0.00% | 51.42K | Dec 21 | View |
| Nov 25, 2020 | Peter Zippelius | — | 0.00 | $74.40 | -$268.10M | DERIVATIVE CONVERSION | 0.00% | 6.43K | Nov 23 | View |
| Nov 12, 2020 | Steven Fasman | — | -2.42K | $100.99 | -$244.90K | SELL | -3.19% | 73.50K | Nov 11 | View |
| Oct 16, 2020 | Kay Schmidt | — | -2.98K | $93.15 | -$278.04K | SELL | -15.92% | 15.76K | Oct 14 | View |
| Oct 16, 2020 | Steven Fasman | — | 0.00 | $59.64 | -$1.01M | TAX | 0.00% | 75.92K | Oct 14 | View |
| Oct 13, 2020 | Michael Grippo | — | -1.68K | $94.99 | -$159.58K | SELL | -8.90% | 17.20K | Oct 12 | View |
| Oct 09, 2020 | Jonathan Arnold | — | 0.00 | $61.17 | -$2.39M | TAX | 0.00% | 38.62K | Oct 07 | View |
| Oct 05, 2020 | Scott Gunther | — | -2.21K | $60.60 | -$549.66K | TAX | -11.70% | 16.69K | Oct 02 | View |
| Oct 05, 2020 | John Chiminski | — | -130.35K | $57.96 | -$18.96M | TAX | -42.88% | 173.62K | Oct 02 | View |
| Sep 08, 2020 | Michael Grippo | — | -2.25K | $89.50 | -$201.38K | SELL | -10.65% | 18.88K | Sep 02 | View |
| Aug 03, 2020 | GREGORY LUCIER | — | -24.00K | $90.09 | -$2.16M | SELL | -52.19% | 21.99K | Jul 30 | View |
| Jul 01, 2020 | Scott Gunther | — | -2.82K | $72.00 | -$203.32K | SELL | -17.44% | 13.37K | Jun 29 | View |
| Jun 29, 2020 | Aristippos Gennadios | — | 0.00 | $50.49 | -$1.00M | TAX | 0.00% | 44.52K | Jun 25 | View |
| Feb 14, 2020 | GREGORY LUCIER | — | 2.00K | $59.71 | $119.42K | PURCHASE | 4.55% | 45.99K | Feb 13 | View |
| Dec 18, 2019 | Alessandro Maselli | PRESIDENT & COO | -7.27K | $53.18 | -$386.51K | SELL | -36.21% | 12.80K | Dec 16 | View |
| Nov 27, 2019 | Ricardo Pravda | SVP & CHIEF HR OFFICER | -2.61K | $52.73 | -$137.72K | SELL | -19.41% | 10.85K | Nov 26 | View |
| Nov 27, 2019 | Aristippos Gennadios | PRESIDENT SOFTGEL & ORAL TECH | 9.00 | $35.45 | -$4.24M | SELL-OPTIONS | 0.02% | 44.24K | Nov 25 | View |
| Nov 26, 2019 | Michael Grippo | SVP, STRATEGY & CORP. DEV. | -376.00 | $52.00 | -$19.55K | SELL | -3.39% | 10.70K | Nov 22 | View |
| Oct 09, 2019 | John Chiminski | CHAIR & CEO | -83.58K | $36.62 | -$5.24M | SELL | -27.15% | 224.26K | Oct 07 | View |
| Sep 11, 2019 | GREGORY LUCIER | DIRECTOR | 2.00K | $51.64 | $103.28K | BUY | 5.42% | 38.92K | Sep 05 - Sep 09 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.